MedTrace Logo

Registering Genomics and Imaging of Tumors (ReGIT)

NCT05386043 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-09-15

No results posted yet for this study

Summary

This study is investigating how brain tumors might mutate over time, and whether new brain imaging tools like MRI and PET can predict these mutations.

Conditions

Interventions

DRUG

FET F-18

PET scan with FET prior to biopsy

DRUG

O-15 Radioisotope

PET scan with O-15 Water prior to biopsy

PROCEDURE

CT scan

CT scan prior to biopsy

PROCEDURE

MRI with gadolinium-based contrast

MRI prior to biopsy

PROCEDURE

Biopsy Collection

Biopsy collection during standard of care neurosurgery for glioma diagnosis/excision

Sponsors & Collaborators

Principal Investigators

  • Jason Parker, PhD · Indiana University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-18
Primary Completion
2030-07-17
Completion
2032-07-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05386043 on ClinicalTrials.gov